Enteral versus Parenteral Glutamine Supplementation in the Critically ill Patient: Pros and Cons
|
|
- Clemence Manning
- 5 years ago
- Views:
Transcription
1 To Our Readers The current issue of the Update Series (27) on Nutrition in Disease Management features a manuscript on the pros and cons of enteral versus parenteral glutamine supplementation presented as a review and is the lead article in this issue. The author is an international expert on glutamine and the information contained in the manuscript clarifies many issues pertaining to glutamine supplementation in the hospital setting and discusses in detail the merits and demerits of enteral versus parenteral glutamine supplementation. The second article in this issue is a viewpoint reminding the reader that safe and effective packaging in order to ensure appropriate hygiene is an essential component of hospital-based nutritional intervention using oral or enteral formulations. The case study is an example of a practical situation in a hospital setting necessitating administration of total parenteral nutrition (TPN) and the importance of achieving the required fluid, energy and nutrients gradually rather than abruptly. This issue also contains an announcement regarding the National Conference on Pancreatic Diseases being held on August 6-7, 2005 at New Delhi. The faculty involved in the Scientific Programme of this Meeting includes scientists who have contributed significantly to work in this discipline. Dr Sarath Gopalan Executive Director, CRNSS, & Editor Edited by: Sarath Gopalan Executive Director, CRNSS and Sakshi Bhushan (Assistant Editor), Designed and produced by Media Workshop India Pvt Ltd. Enteral versus Parenteral Glutamine Supplementation in the Critically ill Patient: Pros and Cons Gil Hardy PhD FRSC and Ines Hardy BPharm Nutraceuticals Research Group School of Pharmacy University of Auckland New Zealand (g.hardy@auckland.ac.nz) INTRODUCTION It is now 30 years since the concepts of immunonutrition and pharmaconutrition emerged. These exciting developments stimulated intense and sometimes controversial debate with an exponential increase in scientific and clinical investigations. In this review the term pharmaconutrient will be used in preference to immunonutrient for glutamine (GLN) because this amino acid has many unique pharmacological and metabolic functions in addition to immune modulation. LGLN is a precursor for purines and pyrimidines, plays an important role in gluconeogenesis, renal ammoniagenesis and in the maintenance of acid-base balance1. It serves as the primary fuel for enterocytes, lymphocytes and other rapidly dividing cells of the immune system.
2 There is substantial animal work demonstrating that GLN becomes conditionally essential under stressful situations, where the body cannot make sufficient quantities. GLN is also a rate limiting substrate for the antioxidant glutathione. Intestinal mucosa produces reactive oxygen species during ischaemia and is therefore susceptible to free radical damage when blood circulation is restored. Additionally surgical trauma and severe illness are associated with profound glutathione and GLN depletion2, 3 in muscle and blood4. Supplementary GLN has been shown to give mucosal protection and attenuate glutathione levels via conversion to glutamate, a constituent of the tri-peptide glutathione5,6 which may explain some of the clinically beneficial effects of GLN. GLN also enhances the ability of the gut to withstand chemical and radiation injury and stimulates the immune system to mount an effective defence in response to infection. Good human evidence now exists that GLN provision has beneficial effects on morbidity and mortality in critically ill adult7 and paediatric patients8. All patients should receive optimal nutritional support. However, the on-going debate between Parenteral (PN) and Enteral Nutrition (EN) now encompasses pharmaconutrition. Side effects, complications and limitations of both modes of administration can be listed ad nauseam9 but favouring one or the other will not benefit the patient10. When used inappropriately, overfeeding or refeeding syndrome can be a problem with PN. Conversely mortality rates have been higher with EN11 and the patient s total nutritional needs are difficult to meet enterally. Consequently, responsible use of both therapies where necessary in combination, taking the patient s condition into account is the best approach. GLN stability and formulation issues, have now been largely resolved by aseptic and lyophilisation technologies12 or by the industrial manufacture of artificial heat stable glutamine dipeptides (GLND)13. Pharmaconutrition is still complicated by the heterogeneity of patient groups and difficulties in interpreting the results of therapy, but there is now good evidence to support the benefits of GLNPN. Current evidence for GLNEN is growing although less compelling, but neither method of supplementation is harmful. But which route should we choose? GLUTAMINE DEPLETION IN METABOLIC STRESS In critical illness and conditions of catabolic stress, the body s demand for LGLN exceeds the capacity for synthesis. Up to 60% GLN depletion occurs following multiple trauma, burns, serious infections, inflammatory intestinal disorders or in those who remain critically ill for more than a few days after major surgery. It can have serious detrimental effects on immune function and gut integrity, thus increasing susceptibility to infection. Immune system activation with its requirement for increased protein synthesis and GLN utilisation14 is one explanation for the large fluxes of GLN from skeletal muscle and provides a rationale for GLN supplementation15. Muscle GLN levels recover very slowly and may not return to normal for many weeks after trauma. Plasma GLN is more responsive and may be a good surrogate parameter to titrate the dosage of GLN necessary to restore GLN balance. High ICU mortality correlates well with low plasma GLN, despite only a marginal difference in APACHE II scores. Thus, plasma GLN has high specificity as an indicator of intracellular depletion and can serve as a useful outcome predictor independent of illness severity16. In practice this means that low plasma GLN concentration warrants exogenous PN or EN supplementation. But what are the pros and cons of each? PARENTERAL GLUTAMINE SUPPLEMENTATION Patients are more likely to receive the prescribed dose of GLN from GLNPN than by the oral or enteral route. Moreover PN guarantees systemic distribution of GLN including the GI tract and immune system where GLN restores T-cell mediated immunity17, reduces the inflammatory response18 and reinforces antioxidant defences19. In a groundbreaking study by Griffiths et al20 the mortality after 6 months in a mixed medical and surgical ICU with one or more organ failures was significantly reduced to 43% with L-GLN enriched PN (GLNPN) at 0.26g/kg/d compared with the controls (67%). GLN supplementation also resulted in a 25% reduction in the cost of intensive care and a 15% reduction in hospital costs for all GLNPN patients. Moreover the total ICU and hospital cost per survivor was reduced by 50% and average length of stay (LOS) in the ICU was reduced from 48 to 25 days (p< 0.012)
3 The author s subsequent analysis of microbiological data21 and overall rates of intensive care acquired infections (ICAI) suggest that the improved survival may be related to reduce mortality from multiple organ failure (MOF). Patients receiving GLN developed fewer Candida infections after a longer ICU stay and none of those infected died, whereas many control patients on standard PN became infected earlier and died from MOF (p=0.02). Specifically, renal failure deaths were lower with GLN (p<0.02). The incidence of Candida infection was in fact halved in the GLN group. Not only did it take longer for infections to develop but also the GLN patients appeared to be able to survive infection better. Patients in this study were extremely ill (APACHE II 17-18) and if they survived, would have been expected to stay in the ICU for many days. Long stay patients frequently suffer from one or more infections, of which Candida albicans is the most common fungal organism. The difference in mortality almost exclusively relates to those patients requiring medium to long term PN and who were likely to die of MOF. The importance of dose and duration of PN has been emphasised in recent European studies. Glutamine-dipeptide (GDPN) at 0.3g GLN/kg was associated with a significant reduction in complications: 41.4% vs. 60.7% (P<0.05) with reduced infection rate and pneumonias (10 vs 19, P<0.05) but outcome could not be determined from median feed durations of only 6-7 days22. In contrast ICU patients receiving a lower dose of GDPN (equiv to 0.2g GLN/kg) for over 9 days survived better than those fed for a shorter time (22/33 versus 13/35, p<0.05)23. In patients with secondary peritonitis, GDPN at 0.4g/kg/body weight/day (equiv to 0.26g/kg GLN) significantly decreased incidence of complications due to infection (4 vs 12, p=0.005) and improved nitrogen balance. IgA returned to normal, along with a trend to improved CD4/CD8 lymphocytes24. GDPN for at least 14 days also prevented the occurrence of pancreatic infection as reported by Chinese investigators25. In summary; GLNPN may not always decrease the risk of infection, but it can decrease the risk of dying from an infection if therapy is continued for long enough. ENTERAL GLUTAMINE SUPPLEMENTATION Absorption of GLN by the gut is good in most ICU patients. Enteral GLN (GLNEN) is utilised by the enterocytes and immune competent cells in the upper gastrointestinal tract. However, the proportion of GLN that actually reaches the general circulation is low26. Since correcting a deficiency is central to the pharmaconutritional effect of GLN the failure of many studies can be explained by this limited systemic availability of GLN from enteral feeds. Several investigations have confirmed that GLNEN improves immune function In a controlled study with 72 ICU patients infectious morbidity was significantly reduced in the GLN group: pneumonia: 5/29 vs. 14/31, (p<0.02), bacteraemia: 2/29 vs. 13/31, (p<0.005), and sepsis: 1/29 vs. 8/31, (p<0.02)28. Another prospective randomised single-blind trial in 84 patients with systemic inflammatory response syndrome had to be finished earlier than planned due to the significantly higher infection rate in the control group (17/33 versus 11/43 in the GLN group, p=0.02)29. For the GLNEN arm of the Liverpool study patients actually received less energy per day than LGPN patients, reflecting the practical limitations with enteral feed delivery in ICU s Nitrogen intake was similar in both groups during the first five days but there was a tendency for control patients to need longer ICU stays (median 16.5d) and receive enteral feeding for longer. Nevertheless, LOS and cost of GLN survivors were reduced. In another randomised trial, multiple trauma patients with depressed HLA-DR expression on monocytes, showed enhanced recovery after two weeks with GLNEN compared with controls31 and in a recent prospective, controlled randomised trial involving 41 adult burn patients32 GLNEN reduced blood infection threefold and prevented bacteraemia with P. aeruginosa. Mortality was significantly lower in patients receiving GLN (0 versus 8 deaths in control group, p < 0.01). Neu et al8 randomly assigned very low birth weight (vlbw) babies to a mixed regimen of PN and EN with or without GLN. In the unsupplemented group 10/35 (30%) babies developed bacteraemia and hospitalacquired sepsis compared to only 4/34 (11%) in the GLNEN group (0.3g /kg/day) (p=0.048). Hospital costs with GLNEN treated vlbw babies33 were also less.
4 Whilst it has been difficult to show an effect on mortality with continuous GLNEN, it must be remembered that patients who are successfully fed by the enteral route are generally less seriously ill with a lower mortality rate. This makes it more difficult to demonstrate a significant outcome effect. Consequently the demonstrable benefits in this group of patients reflect morbidity parameters. GLNEN has been shown to reduce LOS in hospital and ICU as well as the total cost per survivor30. The sicker the patient the greater the likelihood of GLN deficiency and therefore increased mortality risk, yet the more difficult it is in practice to deliver adequate GLNEN to significantly influence survival, making clinical evidence less powerful than data from GLNPN. DOSAGE AND ADMINISTRATION As a pharmaco-nutrient L-GLN may have a direct effect on the immune system and its efficacy is probably related to the dose34 but the precise mechanisms are unclear. Pharmacological doses of GLN, achieving 4mM plasma levels decrease TNF-alpha release and increase HSP 72 expression in human peripheral blood mononuclear cells35. In stressed patients the production rate of GLN may be near normal but there is increased metabolic clearance from plasma, consistent with increased utilisation by other tissues36. GLNPN dosages to reduce mortality are typically 15-24g GLN every 24hrs20,32. Dosing studies show that up to 40g of parenteral GLN per day restores plasma levels to normal26,37. Consequently dosage of g/kg/d for adults with early initiation of nutrition support and at least 5 days of GLN supplementation is usually ecommended38. The dosage can be adjusted up to 40g per day (0.57g/kg/d) for larger patients, major burns39 or severe malabsorption such as short bowel syndrome40. Certainly, at a GLNPN dose of 0.57g/kg/d Wischmeyer et al39 have demonstrated that patients with severe burns show improvement in nutritional status with significant rise in serum transferrin and albumin coupled with fewer inflammatory and bacteraemic episodes and a significant reduction in septicaemia. Paediatric doses normally range from g/kg/d8, however in a recent study a safe upper dose of 0.65g/kg/d was established for oral GLN41. Delivery of 30g/day of GLN jejunally in multiple-trauma patients led to a significant reduction in pneumonia, bacteraemia and severe sepsis. Trauma patients showed a potentially beneficial rise in the CD4-CD8 T-cell ratio42. A recent study in adult patients given GLNEN showed a reduction in systemic infections and a lower mortality rate but importantly, the supplemented GLN was not given as a constant infusion, rather by 4-hour boluses up to a total of 26g/d32. Bolus enteral delivery is potentially more likely to alter GLN levels in the systemic circulation so that one might consider a combination of GLNEN with GLNPN to guarantee the patient the prescribed GLN dose regardless of which therapy is deemed most appropriate. SAFETY AND EFFICACY All the reported studies of oral and enteral supplementation have utilised pure L-GLN, which is moderately soluble in water and common drinks43 with good clinical tolerance. After oral administration absorption leads to increased plasma GLN levels within 30 minutes in healthy volunteers44. No adverse effects have been shown for doses up to 0.65g/kg/d and there are so far no contraindications. Similarly there are no reports that intravenous GLN, using L-GLN or a GLN-dipeptide, produces toxic effects. Addition of 20-40g of dietary GLN during stress will not dramatically change the turnover of GLN, estimated at g/24hrs in normalsized adults. The quantities supplemented in GLN-enriched feeds can therefore be handled according to normal physiological pathways45 with no marked differences in nutritional status or plasma aminogram between GLNEN and GLNPN for most patients46.
5 SYSTEMATIC REVIEWS, META-ANALYSES AND EXPERT RECOMMENDATIONS Large prospective randomised controlled trials may not be suited to pharmaconutrition studies. Inclusion/exclusion criteria may limit study size, patient enrolment or deny life-saving nutrition support in many institutions. Meta-analysis of multiple clinical studies helps to provide statistical significance from combined data and has confirmed that a conditional deficiency of GLN, which adversely influences outcome, occurs in the critically ill. Analysis of 14 randomised supplementation studies with 737 critically ill and surgical patients confirmed that GLNPN reduces the rate of infectious complications (risk ratio 0.79, 95% CI ) and LOS in hospital with a trend towards reduction in mortality (7). A more recent meta-analysis47 strongly supports the hypothesis that GLNPN reduces mortality (RR 0.71, 95% CI ) and is associated with lower infection rates (RR0.81, 95CI days). It confirms that GLNEN has no effect on mortality (RR 1.08, 95% CI ), compared to GLNPN, but overall GLN is associated with lower infection rates (RR 0.81:95% CI, ) supporting the earlier systematic review of 16 studies with 583 patients concluding that GLNEN improves immune function in multiple trauma, reduces costs in critical illness and improves mucositis in post-chemotherapy cancer patients46. Based upon a new meta-analysis of five studies, including two level 1 studies the Canadian Guidelines advise that where available in ICU, PN should contain GLN48. This conclusion has been endorsed by a European consensus group49. Although some different conclusions were reached by both aforementioned Spanish meta-analyses46,47, all investigators recommend the use of GLN pharmaconutrition for ICU patients. CONCLUSION Nutrition support is of fundamental importance to critically ill patients. While it is preferable for patients to receive their nutrition by the enteral route, this is not always possible and parenteral supplementation may be required. Nutrition support provided on an intention to treat basis means that patients are fed enterally as long as necessary. For the majority of ICU patients this approach is beneficial but longstayers who can only be fed parenterally, should receive supplementary GLN. The principal objective of intensive care is to prevent death from MOF and correction of GLN deficiency can help improve the chance of survival. Insufficient GLN supply to important tissues explains why low plasma GLN can be an independent predictor for poor outcome. It is reasonable to assume it could take months for the immune system to return to strength after leaving ICU, which is why the Griffiths six months outcome publications20, 21 are so important for relating pharmaconutrition to the risk of death associated with ICU stay. GLN therapy may not reduce the overall incidence of ICAI but could be valuable supportive therapy to reduce the risk of dying from infection or MOF and make more efficient use of ICU resources. As Hammerqvist50 has eloquently stated: Nutrition in the ICU involves a large amount of Gut Feeling, some Gut Feeding, but not uncritical Gut Filling. We can confidently add that Gut Fuelling requires Glutamine supplementation by Parenteral or Enteral Nutrition. REFERENCES 1. Krebs H.A. The synthesis of glutamine from glutamic acid and ammonia, and the enzymatic hydrolysis of glutamine in animal tissue. Biochem J, 29: Hammarqvist F, Luo JL, Cotgreave IA, Andersson K Wernerman J. Skeletal muscle glutathione is depleted in critically ill patients. Crit Care Med, 25: 78-84, 1997
6 3. Luo JL, Hammarqvist F, Andersson K, Wernerman J. Surgical trauma decreases glutathione synthetic capacity in human skeletal muscle tissue. Am J Physiol, 275: E , Flaring U, Rooyackers O, Hebert C, Hammerqvist F, Wernerman J Longitudinal changes in whole blood glutathione in ICU patients. Clin Nutr, 22: S48, Ikeda S, Zarzaur BL, Johson CD et al. Total parenteral nutrition supplementation with glutamine improves survival after gut ischaemia/reperfusion. JPEN, 26: , Flaring U, Rooyackers O, Wernerman J, Hammerqvist F Glutamine attenuates post-traumatic glutathione depletion in human muscle. Clin Sci, 104: , Novak F, Heyland DK, Avenell A, Drover JW, Xiangyao S. Glutamine supplementation in serious illness: a systematic review of the evidence. Crit Care Med, 30: , Neu J Roig JC, Meetze WH et al et al. Enteral glutamine supplementation for very low birth weight infants decreases morbidity. J Pediatr, 131: , Marik PE, Pinsky M. Death by parenteral nutrition. Intens Care Med, 29: , Varga P, Griffiths RD et al Is parenteral nutrition guilty? Intens Care Med, 29, Woodcock NP, Zeigler D et al Enteral nutrition versus parenteral nutrition: a pragmatic study. Nutrition, 17: 1-12, Hardy G, Marin A, Torre A. Lyophilised amino acid preparations containing L-glutamine. Proc Nutr Soc, 61: 10A, Furst P, Alteheld B, Stehle P. The remarkable story of glutamine dipeptides. Clin Nutr, Supp 1: 3-15, Powell-Tuck J et al: A double blind randomised controlled trial of glutamine-supplementation in parenteral nutrition. Gut, 45: 82-88, Ziegler TR et al: Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation. Ann Int Med, 116: , Oudemans-van Straaten HM, Bosman RJ, Treskes M, van der Spoel HJ, Zansdra DF Plasma glutamine depletion and patient outcome in acute ICU admission. Intens.Care Med, 27: 84-90, Newsholme EA. Importance of glutamine in nutrition of the immune system. Clin Nutr, 14: , Coeffler M, Marion R, Ducrotte P, Dechelotte P. Modulating effect of glutamine on IL-1B-induced cytokine production by human gut. Clin Nutr, 22: , Mates JM, Perez-Gomez C et al Glutamine and its relationship with intracellular redox status. Int J Biochem Cell Biol, 34: , Griffiths RD et al: Six-month outcome of critically ill patients given glutamine-supplemented parenteral nutrition. Nutrition, 13: , Griffiths RD et al: Infection, Multiple Organ Failure and Death in the ICU: Influence of Glutamine- Supplemented Parenteral nutrition on Intensive-Care-Acquired Infection and Survival. Nutrition, 18: , Dechelotte P, Bleicher G, Hasselmann M et al. Improved clinical outcome in ICU patients receiving alanyl-glutamine supplemented total parenteral nutrition (TPN). A French double blind multi-center study. Clin Nutr, 21: 1 (abstract), Goeters C, Wenn A, Mertes N et al. Parenteral L-alanyl-Lglutamine improves 6-month outcome in critically ill patients. Crit Care Med, 30: , Fuentes Orozco C, Anaya-Prado R, Gonzalez-Ojeda A et al. L-alanyl-Lglutamine supplemented parenteral nutrition improves infectious morbidity in secondary peritonitis. Clin Nutr, 23: 13-21, Xian-Li He, Qing-jio Ma et al Effect of TPN with and without glutamine dipeptide supplementation on outcome in severe acute pancreatitis. Clin Nutr, Suppl 1: 43-47, Wernerman J suggestion for present and future use of parenteral glutamine. Clin Nutr, Supp 1: 37-42, Jensen GL et al. A double blind, prospective randomised study of glutamine-enriched compared with standard peptide-based feeding in critically ill patients. Am J Clin Nutr, 64: 615, Houdijk AP et al. Randomised trial of glutamine-enriched enteral nutrition on infectious morbidity in patients with multiple traumas. Lancet, 352: 772, Conejero R et al. Effect of a glutamine-enriched enteral diet on intestinal permeability and infectious morbidity at 28 days in critically ill patients with systemic inflammatory response syndrome: a randomised, single blind, prospective, multicenter study. Nutrition, 18: , 2002
7 30. Jones C et al. Randomised clinical outcome study of critically ill patients given glutaminesupplemented enteral nutrition. Nutrition, 15: , Boelens PG, Houdijk AP, Fonk JC et al. Glutamine-enriched enteral nutrition increases HLA-DR expression on monocytes of trauma patients. J Nutr, 132: , Garrell D, Patenaude J, Nedelec B et al. Decreased mortality and infectious morbidity in adult burn patients given enteral glutamine supplements: a prospective, controlled, randomised clinical trial. Crit Care Med, 31: , Dallas MJ et al. Enteral glutamine supplementation for very low birth weight infants decreases hospital costs. JPEN, 22: , Schloerb P & Amare M: Total parenteral nutrition with glutamine in bone marrow transplantation and other clinical applications (A randomised, double-blind study). JPEN, 17: , Wischmeyer PE, Riehm J, Singleton KD, et al. Glutamine attenuates tumour necrosis factor-á release and enhances heat shock protein 72 in human peripheral blood mononuclear cells. Nutrition, 19: 1-6, Jackson NC, Carroll PV, Russell-Jones DL, Sönksen PH, Treacher DF, Umpleby AM. The metabolic consequences of critical illness: acute effects on glutamine and protein metabolism. Am J Physiol Endocrinol Metab, 276: E , Tjäder I, Rooyackers O, Forsberg AM, Vesali RF, Garlick PJ, Werrnerman J. Effects of skeletal muscle intravenous glutamine supplementation to ICU patients. Intens Care Med, 30: , Griffiths RD. Glutamine in the critically ill patient: can it affect mortality? Clin Nutr, Suppl 1: 25-32, Wischmeyer PE, Lynch J, Liedel J et al. Glutamine administration reduces gram-negative bacteraemia in severely burned patients: a prosective randomised double-blind trial versus isonitrogenous control. Crit Care Med, 29: , Coeffler M, Marion R, Ducrotte P, Dechelotte P. Modulating effect of glutamine on IL-1B-induced cytokine production by human gut. Clin Nutr, 22: , Ward E et al. Oral glutamine in paediatric oncology patients: a dose finding study. Eur J of Clin Nutr, 57: 31-36, Houdijk APJ, Rijnsburger ER, Jansen J et al. Randomised trial of glutamine-enriched enteral nutrition on infectious morbidity in patients with multiple trauma. Lancet, 352: , Hardy G, Sladen H. Stability of L-glutamine in a variety of drinks for oral administration. Nutrition, 13: 760, Castell LM, Newsholme EA. The effects of oral glutamine supplementation on athletes after prolonged exhaustive exercise. Nutrition, 13: , Van Acker BAC, Hulsewe KWE, Wagenmakers AJM et al. Response of glutamine metabolism to glutamine-supplemented parenteral nutrition. Am J Clin Nutr, 72: , Garcia de Lorenzo A et al Clinical evidence for enteral nutritional support with glutamine: a systematic review. Nutrition, 19: , Montejo JC, Zarazag A, Lopez-Martinez J et al. Immunonutrition in the intensive care unit. A systematic review and consensus statement. Clin Nutr, 22: , Heyland DK, Dhaliwal R, et al. Canadian clinical practice guidelines for nutritional support in mechanically ventilated critically ill adult patients. JPEN, 27: , J MacFie. European round table: the use of immunonutrients in the critically ill. Clin Nutr, 23: , Hammerqvist F. Can it all be done by enteral nutrition? Curr Opin Clin Nutr Metab Care, 7: , 2004
What other beneficial effects might GLN exert in critical illness??
What other beneficial effects might GLN exert in critical illness?? Prevention of Enhanced Gut Permeability Who believes bacteria translocate from the gut to blood and cause infection? Yes No Bacteria
More informationPharmaconutrition in PICU. Gan Chin Seng Paediatric Intensivist UMMC
Pharmaconutrition in PICU Gan Chin Seng Paediatric Intensivist UMMC Pharmaconutrition in Critical Care Unit Gan Chin Seng Paediatric Intensivist UMMC Definition New concept Treatment with specific nutrients
More informationAbout OMICS International
About OMICS International OMICS International through its Open Access Initiative is committed to make genuine and reliable contributions to the scientific community. OMICS International hosts over 700
More information8.0 Parenteral Nutrition vs. Standard care May 2015
8.0 Parenteral Nutrition vs. Standard care May 015 015 Recommendation: Based on 6 level studies, in critically ill patients with an intact gastrointestinal tract, we recommend that parenteral nutrition
More informationpatients : review of advances in last five years Dr. Aditya Jindal
Enteral nutrition in medical ICU patients : review of advances in last five years Dr. Aditya Jindal Our food should be our medicine and our medicine should be our food. Hippocrates Introduction ti Nutritional
More informationICU NUTRITION UPDATE : ESPEN GUIDELINES Mirey Karavetian Assistant Professor Zayed University
ICU NUTRITION UPDATE : ESPEN GUIDELINES 2018 Mirey Karavetian Assistant Professor Zayed University http://www.espen.org/files/espen- Guidelines/ESPEN_Guideline_on_clinical_nutrition_in_-ICU.pdf Medical
More informationProtein in Critically Ill Patients. Ashraf El Houfi. MD MS(pulmonology) MRCP(UK) FRCP(London) EDIC Consultant ICU Dubai Hospital
Protein in Critically Ill Patients Ashraf El Houfi. MD MS(pulmonology) MRCP(UK) FRCP(London) EDIC Consultant ICU Dubai Hospital Proteins Proteins Protein is needed to Build, Maintain, and Repair body tissue
More informationEndogenous glutamine production in critically ill patients: the effect of exogenous glutamine supplementation
Mori et al. Critical Care 2014, 18:R72 RESEARCH Open Access Endogenous glutamine production in critically ill patients: the effect of exogenous glutamine supplementation Maiko Mori, Olav Rooyackers, Marie
More informationAmino acids: the forgotten building blocks? Vanessa Kotze RD(SA) Lecturer: Dpt of Human Nutrition
Amino acids: the forgotten building blocks? Vanessa Kotze RD(SA) Lecturer: Dpt of Human Nutrition Focus of presentation Adult critical illness Each amino acid Protein synthesis properties Evidence Guidelines
More informationParenteral glutamine supplementation in critical illness: a systematic review
Wischmeyer et al. Critical Care 2014, 18:R76 RESEARCH Open Access Parenteral glutamine supplementation in critical illness: a systematic review Paul E Wischmeyer 1*, Rupinder Dhaliwal 2, Michele McCall
More informationENTERAL NUTRITION IN THE CRITICALLY ILL
ENTERAL NUTRITION IN THE CRITICALLY ILL 1 Ebb phase Flow phase acute response (catabolic) adoptive response (anabolic) 2 3 Metabolic Response to Stress (catabolic phase) Glucose and Protein Metabolism
More informationNutrition and Sepsis
Nutrition and Sepsis Todd W. Rice, MD, MSc Associate Professor of Medicine Vanderbilt University 2017 DNS Symposium June 2, 2017 Case 55 y.o. male COPD, DM, HTN, presents with pneumonia and septic shock.
More informationNO DISCLOSURES 5/9/2015
Annette Stralovich-Romani, RD, CNSC Adult Critical Care Nutritionist UCSF Medical Center NO DISCLOSURES Incidence & consequences of malnutrition Underfeeding in the ICU Causes/ consequences Nutrition intervention
More information11.1 Supplemental Antioxidant Nutrients: Combined Vitamins and Trace Elements April 2013
. Supplemental Antioxidant Nutrients: Combined Vitamins and Trace Elements April 23 23 Recommendation: Based on 7 level and 7 level 2 studies, the use of supplemental combined vitamins and trace elements
More information4.1 (c) Composition of EN: Glutamine: January 31 st 2009
4.1 (c) Composition of EN: Glutamine: January 31 st 2009 Recommendation: Based on 2 level 1 and 7 level 2 studies, enteral glutamine should be considered in burn and trauma patients. There are insufficient
More information[No conflicts of interest]
[No conflicts of interest] Patients and staff at: Available evidence pre-calories Three meta-analyses: Gramlich L et al. Does enteral nutrition compared to parenteral nutrition result in better outcomes
More informationDr Ahmad Shaltut Othman Anaesthesiologist & Intensivist Hosp Sultanah Bahiyah Alor Setar
FEEDING WITH FISH OIL Dr Ahmad Shaltut Othman Anaesthesiologist & Intensivist Hosp Sultanah Bahiyah Alor Setar New horizons in clinical nutrition from Support to Therapy Landmarks in Parenteral Nutrition
More informationThe Importance of Glutamine and Antioxidant Vitamin Supplementation in HIV
The Importance of Glutamine and Antioxidant Vitamin Supplementation in HIV An Introduction to Glutamine Glutamine is the most abundant amino acid in the human body, and plays extremely important role in
More informationErnährungstherapie des Kritisch Kranken Enteral Parenteral Ganz egal?
Ernährungstherapie des Kritisch Kranken Enteral Parenteral Ganz egal? PD Dr. med. Claudia Heidegger Service des Soins Intensifs Genf/Schweiz Dresden 11. Juni 2016 Nutrition News Nutrition controversy in
More informationIntensive Care Nutrition. Dr Alan Race BSc(Hons) PhD FRCA
Intensive Care Nutrition Dr Alan Race BSc(Hons) PhD FRCA Objectives 1. What examiners say 2. Definition 3. Assessment 4. Requirements 5. Types of delivery 6. CALORIES Trial 7. Timing 8. Immunomodulation
More informationWhat is the Role of Albumin in Sepsis? An Evidenced Based Affair. Justin Belsky MD PGY3 2/6/14
What is the Role of Albumin in Sepsis? An Evidenced Based Affair Justin Belsky MD PGY3 2/6/14 Microcirculation https://www.youtube.com/watch?v=xao1gsyur7q Capillary Leak in Sepsis Asking the RIGHT Question
More informationCurrent concepts in Critical Care Nutrition
Current concepts in Critical Care Nutrition Dr.N.Ramakrishnan AB (Int Med), AB (Crit Care), MMM, FACP, FCCP, FCCM Director, Critical Care Services Apollo Hospitals, Chennai Objectives Why? Enteral or Parenteral
More informationNutrition Support in Critically Ill Cardiothoracic Patients
Nutrition Support in Critically Ill Cardiothoracic Patients อ.นพ.พรพจน เปรมโยธ น สาชาโภชนาการคล น ก ภาคว ชาอาย รศาสตร คณะแพทยศาสตร ศ ร ราชพยาบาล Outline Malnutrition in cardiothoracic patients Nutritional
More informationPlasma glutamine levels in patients after non-elective or elective ICU admission: an observational study
Buter et al. BMC Anesthesiology (2016) 16:15 DOI 10.1186/s12871-016-0180-7 RESEARCH ARTICLE Plasma glutamine levels in patients after non-elective or elective ICU admission: an observational study Hanneke
More informationNutritional intervention in hospitalised paediatric patients. Dr Y.K.Amdekar
Nutritional intervention in hospitalised paediatric patients Dr Y.K.Amdekar Back to basics Suboptimal nutrient intake is always dangerous in health and more so in disease to feed or not to feed is it a
More informationL.Mageswary Dietitian Hospital Selayang
L.Mageswary Dietitian Hospital Selayang 14 15 AUG ASMIC 2015 Learning Objectives 1. To understand the importance of nutrition support in ICU 2. To know the right time to feed 3. To understand the indications
More informationBy; Ashraf El Houfi MD MS (pulmonology) MRCP (UK) FRCP (London) EDIC Consultant ICU Dubai Hospital
By; Ashraf El Houfi MD MS (pulmonology) MRCP (UK) FRCP (London) EDIC Consultant ICU Dubai Hospital Introduction The significance of nutrition in hospital setting (especially the ICU) cannot be overstated.
More informationBenchmarking your ICU s feeding performance: How early is early?
Benchmarking your ICU s feeding performance: How early is early? Dr Gordon S. Doig, Associate Professor in Intensive Care, Northern Clinical School Intensive Care Research Unit, University of Sydney, Sydney,
More informationESPEN Congress The Hague 2017
ESPEN Congress The Hague 2017 Using the gut in acute care patients Permissive underfeeding in practice J.-C. Preiser (BE) PERMISSIVE UNDERFEEDING IN PRACTICE ESPEN congress Jean-Charles Preiser, M.D.,
More informationNutrition and GI. How much?
Nutrition and GI How much? The goal of nutritional supplementation is to meet but not exceed the nutritional requirements of patients with critical illness. Due to the inherent variability between patients
More information3.2 Nutritional Prescription of Enteral Nutrition: Enhanced Dose of Enteral Nutrition May 2015
. Nutritional Prescription of Enteral Nutrition: Enhanced Dose of Enteral Nutrition May 015 015 Recommendation: Based on 1 level 1 study, level studies and cluster randomized controlled trials, when starting
More informationInt. Med J Vol. 6 No 1 June 2007 Enteral Nutrition In Intensive Care: Tiger Tube For Small Bowel Feeding In Acute Pancreatitis.
Page 1 of 6 Int. Med J Vol. 6 No 1 June 2007 Enteral Nutrition In Intensive Care: Tiger Tube For Small Bowel Feeding In Acute Pancreatitis. Case Report Mohd Basri bin Mat Nor. Department of Anaesthesiology
More informationAppendix. This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors.
Appendix This appendix was part of the submitted manuscript and has been peer reviewed It is posted as supplied by the authors Protein delivery and clinical outcomes in the critically ill: A systematic
More informationNutrition care plan. Components and development
Nutrition care plan Components and development Objectives To define the nutrition care plan To present the components of the nutrition care plan To discuss the different approaches in determining the contents
More informationNutrition in Acute Kidney Injury Enrico Fiaccadori
Nutrition in Acute Kidney Injury Enrico Fiaccadori Nephrology Dept. Parma University Medical School Parma, Italy Diagnosis, epidemiology and prognostic impact of proteinenergy wasting (PEW) in AKI Pathogenetic
More informationTPN and lipid. RCT of 57 patients. TPN with lipid vs TPN without lipid. TPN associated with increased infectious complications
TPN and lipid RCT of 57 patients TPN with lipid vs TPN without lipid TPN associated with increased infectious complications * * * * Battistella FD, et al. J Trauma 1997; 43:52. Data Needed 1. New TPN trials
More informationfocus on protein metabolism
Leipzig DGEM 2010 Glutamine and the gut: focus on protein metabolism P. Déchelotte, Rouen, France Gut : a key organ for glutamine metabolism GLN and a target organ modulated by glutamine Clinical benefits
More informationESPEN Congress The Hague 2017
ESPEN Congress The Hague 2017 Meeting nutritional needs of acute care patients Feeding acute pancreatitis patients J. Luttikhold (NL) FEEDING ACUTE PANCREATITIS PATIENTS Joanna Luttikhold, MD PhD Registrar
More informationESPEN Congress Copenhagen 2016
ESPEN Congress Copenhagen 2016 PARENTERAL NUTRITION IN ONCOLOGY PATIENTS INDICATIONS AND CONTRAINDICATIONS F. Bozzetti (IT) Parenteral nutrition in oncology patients indications and contraindications Federico
More informationArginine as an Example of a Conditionally Essential Nutrient: Sickle Cell Disease & Trauma Claudia R. Morris MD, FAAP
Arginine as an Example of a Conditionally Essential Nutrient: Sickle Cell Disease & Trauma Claudia R. Morris MD, FAAP Examining Special Nutritional Requirements in Disease States, A Workshop April 1, 2018
More informationESPEN LLL Programme in Clinical Nutrition and Metabolism. List of Topics and Modules 2014
ESPEN LLL Programme in Clinical Nutrition and Metabolism List of Topics and Modules 204 Code Title Credits for Live course Credits for on-line course Credits for Grading Quiz Topic 0 Introduction in Nutrition
More informationProviding Optimal Nutritional Support on the ICU common problems and practical solutions. Pete Turner Specialist Nutritional Support Dietitian
Providing Optimal Nutritional Support on the ICU common problems and practical solutions Pete Turner Specialist Nutritional Support Dietitian ICU Nutritional Support ACCEPT study showed improved ICU survival
More informationThe Meat and Potatoes of Critical Care Nutrition ROSEMARY KOZAR MD PHD SHOCK TRAUMA UNIVERSITY OF MARYLAND
The Meat and Potatoes of Critical Care Nutrition ROSEMARY KOZAR MD PHD SHOCK TRAUMA UNIVERSITY OF MARYLAND 2013 Canadian Clinical Practice Guidelines www.criticalcarenutrition.com NEJM March 27, 2014 Use
More informationA Randomized Trial of Glutamine and Antioxidants in Critically Ill Patients
original article A Randomized Trial of Glutamine and Antioxidants in Critically Ill Patients Daren Heyland, M.D., John Muscedere, M.D., Paul E. Wischmeyer, M.D., Deborah Cook, M.D., Gwynne Jones, M.D.,
More information/03/ $03.00/0 Vol. 27, No. 5 JOURNAL OF PARENTERAL AND ENTERAL NUTRITION
0148-6071/03/2705-0355$03.00/0 Vol. 27, No. 5 JOURNAL OF PARENTERAL AND ENTERAL NUTRITION Printed in U.S.A. Copyright 2003 by the American Society for Parenteral and Enteral Nutrition Special Interest
More informationFeeding the septic patient How and when? Masterclass ICU nurses
Feeding the septic patient How and when? Masterclass ICU nurses Case Male, 60 - No PMH - L 1.74 m and W 85 kg Pneumococcal pneumonia Stable hemodynamics - No AKI MV in prone position (PEEP 16 - FiO2 60%)
More informationReview Article Glutamine: An Obligatory Parenteral Nutrition Substrate in Critical Care Therapy
BioMed Research International Volume 2015, Article ID 545467, 7 pages http://dx.doi.org/10.1155/2015/545467 Review Article Glutamine: An Obligatory Parenteral Nutrition Substrate in Critical Care Therapy
More informationFeeding the critically ill child
Feeding the critically ill child Khaw Sia (1913 1984) Lee Jan Hau, MBBS, MRCPCH, MCI Children s Intensive Care Unit September 2018 1 2 3 No disclosures Outline Is there a need to optimize enteral nutrition?
More informationNutritional Support in the Perioperative Period
Nutritional Support in the Perioperative Period Topic 17 Module 17.3 Nutritional Support in the Perioperative Period Ken Fearon Learning Objectives Understand the principles behind nutritional care for
More informationVeeradej Pisprasert, MD PhD
Immunonutrition: Asian Perspectives Evidence of Immunonutrition in Asia Veeradej Pisprasert, MD PhD Division of Clinical Nutrition Department of Medicine, Khon Kaen University pveera@kku.ac.th Outline
More informationNutrition care plan for surgical patients. Objectives
Slide 1 Nutrition care plan for surgical patients Surgical Nutrition Training Module Level 1 Philippine Society of General Surgeons Committee on Surgical Training In this session we will discuss the most
More informationClinical Use of Glutamine Supplementation 1,2
The Journal of Nutrition 7th Amino Acid Assessment Workshop Clinical Use of Glutamine Supplementation 1,2 Jan Wernerman* Department of Anesthesia and Intensive Care Medicine, Karolinska University Hospital
More informationNutrition Supplementation in the ICU
Nutrition Supplementation in the ICU ROSEMARY KOZAR MD PHD SHOCK TRAUMA UNIVERSITY OF MARYLAND Canadian Clinical Practice Guidelines www.criticalcarenutrition.com NEJM March 27, 2014 1 Use of Enteral vs
More informationGlutamine represents approximately
The effect of L-alanyl-L-glutamine dipeptide supplemented total parenteral nutrition on infectious morbidity and insulin sensitivity in critically ill patients* Teodoro Grau, MD; Alfonso Bonet, MD; Eduardo
More informationIndex. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A Abdominal pain, enteral therapy in acute pancreatitis and, 812 Abscess(es), pancreatic, nutritional support for, 814 815 Acute Physiology and
More informationGuidelines for the Provision and Assessment of Nutrition Support Therapy in the Pediatric Critically Ill Patient: ASPEN-SCCM 2017
Number of Patients Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Pediatric Critically Ill Patient: ASPEN-SCCM 2017 Jorge A. Coss-Bu, MD Associate Professor of Pediatrics
More informationAntioxidant Dosing and Micronutrient Management in the Intensive Care Unit
PENSA 2017 November 21, 2017 Antioxidant Dosing and Micronutrient Management in the Intensive Care Unit Lingtak-Neander Chan, PharmD, BCNSP, CNSC, FACN Professor of Pharmacy, Interdisciplinary Faculty
More informationTHE PHYSIOLOGICAL IMPACT OF TRAUMA AND INFECTION = The Metabolic Response to Stress
THE PHYSIOLOGICAL IMPACT OF TRAUMA AND INFECTION = The Metabolic Response to Stress JP Pretorius Head: Department of Critical Care Head: Clinical Unit Surgical/Trauma ICU University of Pretoria & Steve
More informationDisclosures. None. Enteral Nutrition and Vasoactive Therapy! But actually.. Stocks Advisory boards Grants Speakers Bureau. Paul Marik, MD,FCCM,FCCP
Enteral Nutrition and Vasoactive Therapy! Paul Marik, MD,FCCM,FCCP Disclosures Stocks Advisory boards Grants Speakers Bureau None But actually.. 1 We suggest a determination of nutrition risk (NUTRIC score)
More informationREducing Deaths from OXidative Stress
C a n adian Critic a The REDOXS Study REducing Deaths due to OXidative Stress The REDOXS Study REducing Deaths from OXidative Stress Study Chair Dr. Daren Heyland, MD, FRCPC Project Leaders Rupinder Dhaliwal,
More informationOklahoma Dietetic Association. Ainsley Malone, MS, RD, LD, CNSD April, 16, 2008 Permissive Underfeeding: What, Where and Why? Mt.
The What, Why and When of Permissive Ainsley Malone, MS, RD, CNSD Nutrition Support Team Mt. Carmel West Hospital Mt. Carmel West 500 bed academic center Non-physician based NST Dietitian, pharmacist and
More informationESPEN Congress Vienna Nutritional implications of renal replacement therapy in ICU Nutritional support - how much nitrogen? W.
ESPEN Congress Vienna 2009 Nutritional implications of renal replacement therapy in ICU Nutritional support - how much nitrogen? W. Druml (Austria) Nutritional Implications of Renal Replacement Therapy
More informationA review on enteral nutrition guidelines for traumatic brain injury
A review on enteral nutrition guidelines for traumatic brain injury According to the Centers for Disease Control and Prevention, at least 1.7 million people suffer from traumatic brain injury (TBI) every
More information5.3 Strategies to Optimize Delivery and Minimize Risks of EN: Small Bowel Feeding vs. Gastric May 2015
5.3 Strategies to Optimize Delivery and Minimize Risks of EN: Small Bowel Feeding vs. Gastric May 2015 2015 Recommendation: Based on 16 level 2 studies, small bowel feeding compared to gastric feeding
More information5.3 Strategies to Optimize Delivery and Minimize Risks of EN: Small Bowel Feeding vs. Gastric February 2014
5.3 Strategies to Optimize Delivery and Minimize Risks of EN: Small Bowel Feeding vs. Gastric February 2014 2013 Recommendation: Based on 15 level 2 studies, small bowel feeding compared to gastric feeding
More information9.1 Composition of Parenteral Nutrition: Branched Chain Amino Acids (BCAA) March 2013
9.1 Composition of Parenteral Nutrition: Branched Chain Amino Acids () March 2013 2013 Recommendation: In patients receiving parenteral nutrition or enteral nutrition, there are insufficient data to make
More informationNutrition Support. John Cha Department of Surgery DHMC/UCHSC
Nutrition Support John Cha Department of Surgery DHMC/UCHSC Overview Why? When? How much? What route? Fancy stuff: enhanced nutrition Advantages of Nutrition Decreased catabolism Improved wound healing
More information10.2 Strategies to Optimize Parenteral Nutrition and Minimize Risks: Use of lipids May 2015
10.2 Strategies to Optimize Parenteral Nutrition and Minimize Risks: Use of lipids May 2015 There are no new randomized controlled trials since the 2009 and 2013 updates and hence there are no changes
More informationThe Role of Glutathione in Cell Defense, with References to Clinical Deficiencies and Treatment. Thomas A. Kwyer, M.D.
The Role of Glutathione in Cell Defense, with References to Clinical Deficiencies and Treatment Thomas A. Kwyer, M.D. Glutathione Precursors: Amino Acids L-Glutamate L-Cysteine the rate-limiting substrate
More informationMalnutrition: An independent Risk Factor for Postoperative Complications
Malnutrition: An independent Risk Factor for Postoperative Complications Bryan P. Hooks, D.O. University of Pittsburgh-Horizon June 24, 2017 Orthopedic Surgeon-Adult Reconstruction Disclosures: None Objectives:
More information5.2 Strategies to Optimize Delivery and Minimize Risks of EN: Motility Agents May 2015
5.2 Strategies to Optimize Delivery and Minimize Risks of EN: Motility Agents May 2015 There were no new randomized controlled trials since the 2009 and 2013 updates and hence there are no changes to the
More information10/3/2012. Pediatric Parenteral Nutrition A Comprehensive Review
Critical Care Nutrition Foundation for Moving Forward Justine Turner MD PhD Department of Pediatric Gastroenterology and Nutrition University of Alberta I have the following financial relationships to
More informationSymposium 4. Hot Topics in Parenteral Nutrition. Supported by an unrestricted educational grant from Baxter
Symposium 4 Hot Topics in Parenteral Nutrition Supported by an unrestricted educational grant from Baxter Rationale for using new lipid emulsions a review of evidence from clinical trials Philip Calder
More informationESPEN Congress Florence 2008
ESPEN Congress Florence 2008 PN Guidelines presentation PN Guidelines in pancreas diseases L. Gianotti (Italy) ESPEN Guidelines on Parenteral Nutrition: Pancreas L.Gianotti, R.Meier, D.N.Lobo, C.Bassi,
More informationTiming of Parenteral Nutrition
Timing of Parenteral Nutrition Arun Bansal; MD, FCCM, MRCPCH Professor Pediatric Critical Care PGIMER, Chandigarh, INDIA drarunbansal@gmail.com Malnutrition in Critically Ill Incidence: from 19 32% Associated
More informationScandinavian glutamine trial: a pragmatic multi-centre randomised clinical trial of intensive care unit patients
Acta Anaesthesiol Scand 2011; 55: 812 818 Printed in Singapore. All rights reserved r 2011 The Authors Acta Anaesthesiologica Scandinavica r 2011 The Acta Anaesthesiologica Scandinavica Foundation ACTA
More informationLa Nutrizione Artificiale dall ospedale al domicilio
La Nutrizione Artificiale dall ospedale al domicilio Federico Bozzetti Cagliari 25-26 Marzo 2009 Nutrition of the cancer patient Prevalence of malnutrition Effect of malnutrition on the outcome: - survival
More informationHealth economics in ICU nutrition: The time has come
Health economics in ICU nutrition: The time has come Dr Gordon S. Doig, Associate Professor in Intensive Care, Northern Clinical School Intensive Care Research Unit, University of Sydney, Sydney, Australia
More informationICU Acquired Weakness: Role of Specific Nutrients
ICU Acquired Weakness: Role of Specific Nutrients Dr Jonathan TAN Senior Consultant Dept of Anaesthesiology, Intensive Care & Pain Medicine Tan Tock Seng Hospital, Singapore Purpose? Healthcare professionals?
More information2.0 Early vs. Delayed Nutrient Intake May 2015
2.0 Early vs. Delayed Nutrient Intake May 2015 There were no new randomized controlled trials since the 2013 update and hence there are no changes to the following summary of evidence. 2013 Recommendation:
More information8.0 Parenteral Nutrition vs. Standard care January 31 st 2009
8.0 Parenteral Nutrition vs. Standard care January 31 st 2009 Recommendation: Based on 5 level 2 studies, in critically ill patients with an intact gastrointestinal tract, we recommend that parenteral
More informationTHE AUTHOR OF THIS WHAT S NEW IN NUTRITION? OBJECTIVES & OUTLINE EVIDENCE-BASED MEDICINE: PARENTERAL NUTRITION (PN)
WHAT S NEW IN NUTRITION? Alisha Mutch, Pharm.D., BCPS THE AUTHOR OF THIS PRESENTATION HAS NOTHING TO DISCLOSE. OBJECTIVES & OUTLINE MALNUTRITION OBJECTIVES Indicate when parenteral nutrition (PN) is warranted
More informationPAEDIATRIC RESPIRATORY FAILURE. Tang Swee Fong Department of Paediatrics University Kebangsaan Malaysia Medical Centre
PAEDIATRIC RESPIRATORY FAILURE Tang Swee Fong Department of Paediatrics University Kebangsaan Malaysia Medical Centre Outline of lecture Bronchiolitis Bronchopulmonary dysplasia Asthma ARDS Bronchiolitis
More information3.2 Nutritional Prescription of Enteral Nutrition: Achieving Target Dose of Enteral Nutrition March 2013
. Nutritional Prescription of Enteral Nutrition: Achieving Target Dose of Enteral Nutrition March 01 There were no new randomized controlled trials since the 009 update and hence there are no changes to
More informationSustamine designed to enhance performance
Sustamine designed to enhance performance Sustamine s Scientific Advantages The U.S. sports nutrition market is valued at $10 billion annually for drinks, shots, bars, gels, and supplements. 1 Sustamine
More informationJournal Club: The Use of Fish Oil Lipid Emulsion for Gastrointestinal Surgery Patients
S a m m i M o n t a g F i s h O i l E m u l s i o n J o u r n a l C l u b - P a g e 1 Journal Club: The Use of Fish Oil Lipid Emulsion for Gastrointestinal Surgery Patients Introduction/Background I. Surgical
More informationParenteral Nutrition Better than Enteral Nutrition in Pediatric Intensive Care Unit (PICU)?
Parenteral Nutrition Better than Enteral Nutrition in Pediatric Intensive Care Unit (PICU)? W. Daza 1, C. Ortegón 2 and S. Dadán 3 1 Pediatrics Gastroenterologist & Master in Clinical Nutrition, Chief
More informationNutritional Issues. Perioperative Nutritional Interventions. A challenging case you are likely familiar with
Perioperative Nutritional Interventions Lygia Stewart MD, John Maa MD, and Annette Romani RD UCSF Post-Graduate Course Nutritional Issues Who needs nutritional supplementation? Oral, feeding tube, or TPN?
More informationMinimal Enteral Nutrition
Abstract Minimal Enteral Nutrition Although parenteral nutrition has been used widely in the management of sick very low birth weight infants, a smooth transition to the enteral route is most desirable.
More informationESPEN Congress Madrid 2018
ESPEN Congress Madrid 2018 New ESPEN Guidelines Nutrition In The ICU P. Singer (IL) ESPEN Guidelines: Nutrition in the ICU Pierre Singer Annika Reintam Blaser Mette M Berger Waleed Alhazzani Philip C Calder
More informationProtein dosing in the ICU: How much, when and why?
Protein dosing in the ICU: How much, when and why? Dr. Gordon S. Doig, Associate Professor in Intensive Care Northern Clinical School Intensive Care Research Unit, University of Sydney, Sydney, Australia
More informationList of Topics and Modules (2012)
List of Topics and Modules (202) Code Title Credits for Live course Topic 0 Introduction to Clinical Nutrition EDU T0 M 0. Introduction to clinical nutrition support Topic Metabolism of Metabolism of Macronutrients,
More informationBasics in clinical nutrition: Trace elements and vitamins in parenteral and enteral nutrition
e-spen, the European e-journal of Clinical Nutrition and Metabolism (2008) 3, e293ee297 e-spen, the European e-journal of Clinical Nutrition and Metabolism http://intl.elsevierhealth.com/journals/espen
More informationBack to the Future: Updated Guidelines for Evaluation and Management of Adrenal Insufficiency in the Critically Ill
Back to the Future: Updated Guidelines for Evaluation and Management of Adrenal Insufficiency in the Critically Ill Joe Palumbo PGY-2 Critical Care Pharmacy Resident Buffalo General Medical Center Disclosures
More informationEnteral Nutrition: Whom, Why, When, What and Where to Feed?
Meier RF, Reddy BR, Soeters PB (eds): The Importance of Nutrition as an Integral Part of Disease Management. Nestlé Nutr Inst Workshop Ser, vol 82, pp 53 59, (DOI: 10.1159/000382002) Nestec Ltd., Vevey/S.
More informationEffect of glutamine supplementation on lymphocyte subsets in children with acute diarrhea
The Turkish Journal of Pediatrics 2010; 52: 262-266 Original Effect of glutamine supplementation on lymphocyte subsets in children with acute diarrhea S. Songül Yalçın 1, Kadriye Yurdakök 1, İlhan Tezcan
More informationIn 1936, Studley noted that patients who had lost 20%
GASTROENTEROLOGY 2001;121:970 1001 AGA Technical Review on Parenteral Nutrition This literature review and the recommendations therein were prepared for the American Gastroenterological Association Clinical
More informationExtremely well tolerated. Feeding shock
Extremely well tolerated Feeding shock FEEDING DURING CIRCULATORY FAILURE Dr S Omar Chris Hani Baragwanath Hospital Hospital/University of Witwatersrand Introduction Circulatory shock lack of adequate
More informationFocus Areas for Entry Test (Technical Part) for M. Phil / PhD in Food & Nutrition
Focus Areas for Entry Test (Technical Part) for M. Phil / PhD in Food & Nutrition Sr. No. Core Areas Percentage 1. 2. Community Nutrition 15% Dietetics and Preventive Nutrition 15% 3. 4. 5. 6. 7. Nutritional
More information